Richard Ronald
SEC CIK 1380177 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | Dir | 123.8K | — | $285.9K | 9 | 2022-05-26 | 2026-04-30 |
Most active insiders at EBS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DeGolyer Donald W | Dir | — | $317.6K |
| 2 | Glessner Coleen | EVP, Quality, Ethics, CPL | — | $306.1K |
| 3 | Richard Ronald | Dir | — | $263.1K |
| 4 | Dayal Sujata Tyagi | Dir | — | $201.1K |
| 5 | Zoon Kathryn C | Dir | — | $144.5K |
| 6 | Katkin Keith | Dir | — | $128.2K |
| 7 | Williams Paul Anthony | SVP, Products Business | — | $59.0K |
| 8 | Lowry Simon C | SVP, CMO, R, D | — | — |
| 9 | Perl Jessica | SVP, GC, Corp Sec | — | — |
| 10 | Hartzel William | SVP, Bioservices | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-04 17:28 | 2026-04-30 | EBS | Emergent BioSolutions Inc. | Richard Ronald | Dir | A - Grant | $0.00 | +25.3K | 123.8K | +26% | $0 |
| DM | 2025-12-09 | 2025-12-05 | EBS | Emergent BioSolutions Inc. | Richard Ronald | Dir | S - Sale+OE | $11.97 | -22.0K | 98.4K | -18% | -$263.1K |
| D | 2025-12-09 | 2025-12-05 | EBS | Emergent BioSolutions Inc. | Richard Ronald | Dir | F - Tax | $11.90 | -10.9K | 113.3K | -9% | -$129.3K |
| D | 2025-12-09 | 2025-12-05 | EBS | Emergent BioSolutions Inc. | Richard Ronald | Dir | M - OptEx | $5.02 | +25.7K | 124.2K | +26% | +$129.3K |
| D | 2025-05-02 | 2025-04-30 | EBS | Emergent BioSolutions Inc. | Richard Ronald | Dir | A - Grant | $0.00 | +34.4K | 105.5K | +48% | $0 |
| D | 2024-05-28 | 2024-05-23 | EBS | Emergent BioSolutions Inc. | Richard Ronald | Dir | A - Grant | $0.00 | +17.4K | 71.1K | +32% | $0 |
| 2023-05-30 | 2023-05-25 | EBS | Emergent BioSolutions Inc. | Richard Ronald | Dir | A - Grant | $0.00 | +33.8K | 53.7K | +171% | $0 | |
| 2022-11-29 | 2022-11-25 | EBS | Emergent BioSolutions Inc. | Richard Ronald | Dir | S - Sale | $11.94 | -1,912 | 19.8K | -9% | -$22.8K | |
| 2022-05-31 | 2022-05-26 | EBS | Emergent BioSolutions Inc. | Richard Ronald | Dir | A - Grant | $0.00 | +8,446 | 21.7K | +63% | $0 |
Purchase Sale Sale after option exercise All abbreviations